Health TrialsbyHealthPanel

Wise Practice of Chinese Hemodialysis (WISHES)

ConditionHaemolyses and Related Conditions
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorSun Yat-sen University

About this trial

The investigators are registering all HD patients at recruited hospitals and developing a HD database in China. Patients will be follow-up every 3 months, and both baseline and follow-up information will be entered into the registration system. The patient survival, technical survival, patency rate of access, quality of life and residual renal function for HD patients will be compared using the HD database.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

None

Disqualifiers

None

Trial population

End stage renal disease patients receiving hemodialysis treatment

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • No intervention

    Other intervention

    Registration of all HD patients in the First Affiliated Hospital of Sun Yat-sen University and other hospital which have signed the contract in China.

Treatment groups

30,000 Participants
are divided into 1 treatment group
Group A: Hemodialysis patients1 intervention

Trial outcomes

Primary outcomes

1

Patient survival of HD patients

Time frame
10 years

Secondary outcomes

1

Quality of life evaluated using SF36 scale for HD patients

Time frame
10 years
2

Patency rate of access for HD patients

Time frame
10 years

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Sun Yat-sen University

Lead sponsor

Source ClinicalTrials.gov
Apply now